Recent News
European Regulator Updates Xeljanz Blood Clot Warning
Drug regulators in the Europe Union have concluded that Xeljanz might increase the risk for dangerous blood clots – pulmonary embolism and deep vein thrombosis — when taken by patients already at heightened risk. As a result, the Pharmacovigilance Risk … Continue reading
Contaminated Zantac Lawsuits Could be Centralized in Single Federal Court
Plaintiffs pursuing lawsuits over contaminated Zantac have requested that their claims be centralized before a single judge in one federal jurisdiction. 15 Zantac Lawsuits Pending in Federal Courts Nationwide According to a Motion for Transfer filed with the U.S. Judicial … Continue reading
Catskills Boys Camp Named in New Child Victims Act Lawsuit
A man who says he was molested by a rabbi while attending a summer camp for Jewish boys in the Catskills decades ago is pursuing a clergy sexual abuse lawsuit under New York’s recently passed Child Victims Act. Plaintiff Attended … Continue reading
Two Florida Women Seek $5 Million for Recalled Biocell Breast Implants
Allergan Inc. is facing yet another lawsuit over recalled Biocell textured breast implants. This latest complaint was filed on October 22nd in the U.S. District Court, Middle District of Florida, and seeks to force Allegan to cover the cost of … Continue reading
FDA Criticized for Downplaying Zantac Cancer Risk
The online pharmacy that first detected a potentially cancer-causing chemical in branded and generic versions of Zantac had sharp words for the U.S. Food & Drug Administration (FDA) late last week, after the agency said its own testing suggested ranitidine … Continue reading
Latest Sex Trafficking Lawsuits Target Hotels in Georgia, New York City
Sex trafficking lawsuits continue to mount in courts around the United States, with the most recent filings targeting hotels in Georgia and New York City. New York Hotels Allegedly Enabled Abuse of 10-year-Old A complaint filed on Tuesday in Brooklyn … Continue reading
FDA Announces Yet Another Class I Recall for Ethicon Surgical Staplers
The U.S. Food & Drug Administration (FDA) has announced yet another Class I recall for surgical staplers marketed by Ethicon, Inc. Ethicon Surgical Stapler Recall Followed Patient Death This latest action involves more than 8,200 Echelon Flex Endopath staplers that … Continue reading
EPA Seeking Public Comment on Paraquat Health & Environmental Dangers
The U.S. Environmental Protection Agency (EPA) is seeking public comments regarding the health and environmental dangers associated with paraquat, a widely used pesticide that has been linked to Parkinson’s disease. Like other pesticides, paraquat must undergo EPA review every 15 … Continue reading
Johnson & Johnson Denied Recusal Bid in $8 Billion Risperdal Verdict
A state court judge in Philadelphia, Pennsylvania has refused to recuse himself from a key Risperdal lawsuit, just weeks after Johnson & Johnson and it’s Janssen Pharmaceuticals unit were ordered to pay $8 billion in punitive damages to a Maryland man … Continue reading
Follow Us
